Measles Vaccine Microneedle Patch Could Simplify Immunizations in Pennsylvania Clinics and Schools

Why it matters locally: The development of a measles vaccine microneedle patch has significant implications for Pennsylvania. Widespread adoption of this technology could drastically improve vaccination rates, particularly in rural areas or communities with limited access to traditional healthcare. By simplifying administration and potentially reducing reliance on trained medical personnel, schools and community clinics across the state could more easily conduct vaccination drives. Considering Pennsylvania's population of nearly 13 million, innovative solutions like this could make a huge difference in public health.

---

Atlanta, GA – A collaborative effort between the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) is focused on creating a microneedle patch designed to deliver measles vaccines. The research team hopes the new technology will offer several advantages over traditional injection methods. The patch utilizes microscopic needles, imperceptible to the naked eye, to administer the vaccine under the skin. This method could potentially eliminate the need for trained medical personnel to administer the shots. The developers hope the patch format will make measles vaccination more accessible in locations with limited resources. While details on the patch's composition and clinical trial timelines remain undisclosed, the project signifies ongoing efforts to improve vaccine delivery systems and combat vaccine-preventable diseases like measles. The project aims to create a more stable, easy-to-administer alternative to traditionally refrigerated and injected vaccines. If successful at scale, this could offer wider access to vaccination which could reduce cases and potential spread of the disease.